Skip to main content

Table 3 Results of objective image quality analysis

From: Optimization of contrast medium volume for abdominal CT in oncologic patients: prospective comparison between fixed and lean body weight-adapted dosing protocols

Parameter

Fixed dose protocol (n = 50)

LBW protocol (n = 50)

p value

Arterial phase

 Liver SNR

5.91 ± 1.88

5.58 ± 1.63

0.346

 Liver CNR

1.72 ± 1.31

1.99 ± 1.27

0.123

 Liver CEI, HU

16.10 ± 9.65

23.02 ± 10.84

< 0.001

 Pancreas SNR

5.59 ± 3.55

5.90 ± 2.37

0.130

 Pancreas CNR

2.92 ± 1.76

3.85 ± 2.04

0.004

 Pancreas CEI, HU

50.66 ± 17.29

66.45 ± 19.78

< 0.001

 Kidney SNR

7.38 ± 4.17

8.19 ± 2.61

0.016

 Kidney CNR

7.90 ± 4.10

9.60 ± 3.55

0.003

 Kidney CEI, HU

122.17 ± 35.68

145.00 ± 42.53

0.002

 Aorta SNR

16.07 ± 5.75

14.56 ± 4.89

0.147

 Aorta CNR

16.57 ± 6.42

17.47 ± 5.86

0.379

Portal venous phase

 Liver SNR

8.10 ± 1.96

8.22 ± 2.13

0.766

 Liver CNR

4.48 ± 1.70

4.37 ± 1.61

0.730

 Liver CEI, HU

59.61 ± 15.21

59.22 ± 11.14

0.796

 Pancreas SNR

5.78 ± 2.37

4.91 ± 1.75

0.079

 Pancreas CNR

2.69 ± 1.66

2.13 ± 1.30

0.065

 Pancreas CEI, HU

55.15 ± 20.42

50.64 ± 13.86

0.220

 Kidney SNR

9.54 ± 2.58

10.05 ± 3.10

0.370

 Kidney CNR

9.95 ± 3.56

9.18 ± 2.21

0.198

 Kidney CEI, HU

78.97 ± 58.75

103.56 ± 30.35

< 0.001

 Portal vein SNR

10.42 ± 3.01

9.33 ± 3.37

0.015

 Portal vein CNR

8.92 ± 3.31

7.57 ± 2.31

0.020

  1. Data are means ± standard deviations
  2. LBW lean body weight, SNR signal-to-noise ratio, CNR contrast-to-noise ratio, CEI contrast enhancement index, HU hounsfield unit